CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Do you know which stock currently entered into uncharted territory & witnessed huge spurt in delivery volumes?
Karan Dsij
/ Categories: Trending

Do you know which stock currently entered into uncharted territory & witnessed huge spurt in delivery volumes?

Poly Medicure is one of the leading medical device companies as well as a major exporter in India. The company has a strong track record of manufacturing high-quality medical devices in eight state-of-the-art manufacturing facilities across the world.   

The stock hit a fresh 52-week high of Rs 570 in the last trading session, which also happens to be the day’s high of Friday’s session. The stock closed around Rs 553.75. It has a recorded volume of over 11.5 lakh, which is the highest daily volume since October 16, 2020. Also, the volumes recorded were greater than its 10 and 30-day average. What is more exciting about this stock apart from the surge in total traded quantity is the delivery quantity and percentage of delivery quantity to traded quantity. The total delivery quantity stood at 7,81,882, which translates into 67.57 per cent of the traded quantity.   

In the quarter ended December 2020, the stock has seen an increase in holdings from the FII/FPI as the holding has increased from 2.86 per cent in September 2020 quarter to 3.75 per cent in December 2020 quarter. This is the highest holding by FII/FPI since December 2019. Further, the numbers of FII/FPI investors have increased from 23 to 30 in December 2020 quarter.   

As an established player of significant scale, the company is set to benefit from various tailwinds in the Indian market. The medical devices export from India outpaces global market growth with a 5-year CAGR of 13 per cent as against global industry growth of 5 per cent mentioned in the investors' presentation of the company.   

Previous Article Bank of Baroda shows notable technical formation
Next Article Capex plans & interest of marquee investors become new dawn for stock
Print
964 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR